CDC23
Cell division cycle protein 23 homolog
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
interacting protein | 1 | ||
biological process | 0.96 | ||
virus perturbation | 0.96 | ||
histone modification site profile | 0.88 | ||
disease perturbation | 0.83 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | APC-Cdc20 mediated degradation of Nek2A | ||||
Reactome | APC/C-mediated degradation of cell cycle proteins | ||||
Reactome | APC/C:Cdc20 mediated degradation of Cyclin B | ||||
Reactome | APC/C:Cdc20 mediated degradation of Securin | ||||
Reactome | APC/C:Cdc20 mediated degradation of mitotic proteins | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
APC-Cdc20 mediated degradation of Nek2A | ||||
APC/C-mediated degradation of cell cycle proteins | ||||
APC/C:Cdc20 mediated degradation of Cyclin B | ||||
APC/C:Cdc20 mediated degradation of Securin | ||||
APC/C:Cdc20 mediated degradation of mitotic proteins | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Traceable Author Statement (TAS) | UniProtKB | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
1 | 1 | 0 | 1.1 | 34.9 | |||||
self reported educational attainment | 1 | 1 | 1 | 30.2 | |||||
mathematical ability | 1 | 1 | 1 | 30.2 | |||||
1 | 1 | 1 | 3.9 | ||||||
Eczema | 1 | 1 | 0 | 1 | 2.1 | ||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
0 | 1.1 | 34.9 | |||||
self reported educational attainment | 1 | 30.2 | |||||
mathematical ability | 1 | 30.2 | |||||
1 | 3.9 | ||||||
Eczema | 0 | 1 | 2.1 | ||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | cell division cycle 23 | VGNC:11875 | 462092 | |||||
Macaque | cell division cycle 23 | 714000 | ||||||
Mouse | MGI:1098815 | 52563 | ||||||
Rat | RGD:1304819 | 291689 | ||||||
Dog | cell division cycle 23 | VGNC:51703 | 481526 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | cell division cycle 23 | |||||
Macaque | cell division cycle 23 | |||||
Mouse | ||||||
Rat | ||||||
Dog | cell division cycle 23 | |||||
PMID | Year | Title |
---|